Under construction – not a live service
Sign in
Taking people in FranceNo phase

Checking fluid buildup in adults with reduced-ejection heart failure before hospital discharge

Studies fluid buildup signs in adults with heart failure before discharge.

Plain-language title generated from the registry record
Registry title: Acute Heart Failure With Reduced Ejection Fraction - COngestion Discharge Evaluation

Key facts

Where
Vandœuvre-lès-Nancy, FranceSee the site

Where in France

  • CHRU de NancyVandœuvre-lès-Nancy, FranceTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Central Hospital, Nancy, France
Trial code
NCT04343443
Record updated
5 June 2023
Original description
The AHF-CODE reduced study is a prospective, non-randomized, monocenter study performed in patients with heart failure with reduced ejection fraction admitted for worsening heart failure.Read full original descriptionShow less

Acute Heart Failure With Reduced Ejection Fraction - COngestion Discharge Evaluation: Evaluation de la Congestion à la Sortie d'Hospitalisation Pour Insuffisance Cardiaque aiguë à Fraction d'éjection altérée ou modérément altérée

The AHF-CODE reduced study is a prospective, non-randomized, monocenter study performed in patients with heart failure with reduced ejection fraction admitted for worsening heart failure.

The main objective of the AHF-CODE study is to identify congestion markers (clinical, biological and ultrasound) at the end of hospitalization for acute heart failure that are associated with the risk of all cause death or rehospitalization for acute heart failure within 3 months of hospital discharge.

Inclusion: Patients hospitalised for acute heart failure; Patients with reduced ejection fraction (Ejection Fraction <40%) or (40% ≤ Ejection Fraction < 50); Patients considered clinically discharging from hospitalisation for acute heart failure; Age ≥18 years; Patients having received complete information regarding the study design and having signed their informed consent form; Patient affiliated to or beneficiary of a social security scheme.

Exclusion: History of lobectomy or pneumonectomy lung surgery; Person subject to psychiatric care pursuant to Articles L. 3212-1 and L. 3213-1 of the Public Health Code; Comorbidity for which the life expectancy is ≤ 3 months; Dialysis patient (peritoneal dialysis or hemodialysis) or patients with glomerular filtration rate <15 ml/min/m2 at inclusion; Severe pulmonary or pleural pathology preventing reliable acquisition of lung ultrasound images: severe emphysema, chronic pleurisy, pulmonary fibrosis, etc; Pregnant woman, parturient or nursing mother; Adult person subject to a legal protection measure (guardianship, curatorship, safeguard of justice) Adult person who is unable to give consent; Person deprived of liberty by a judicial or administrative decision,.

ClinicalTrials.gov NCT04343443